A Phase II Single-centered Randomized Controlled Trials of Concurrent Chemoradiotherapy with S-1 Plus Cisplatin Compared to 5-fluorouracil Plus Cisplatin in Non-operable Esophageal Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2016
At a glance
- Drugs Fluorouracil (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
- Indications Oesophageal cancer
- Focus Therapeutic Use
- Sponsors Shandong New age Pharmaceutical
- 19 Jul 2015 Status changed from not yet recruiting to completed.
- 21 May 2012 Planned end date changed from 1 Oct 2013 to 31 Oct 2016 as reported by Chinese Clinical Trial Register.
- 05 Sep 2011 New trial record